Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Hyperthermia 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1

Interventions

Cisplatin 6pembrolizumab 3Nivolumab 3Magnetic Resonance Spectroscopy 3Fulvestrant 3palbociclib 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Platinum 2Paclitaxel 2Fluorouracil 2Fluorodeoxyglucose F18 2Drug Therapy 2Congresses as Topic 2Carboplatin 2Brachytherapy 2Biopsy 2Bevacizumab 2Axitinib 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2zimberelimab 1ulixertinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1tisotumab vedotin 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Diathermy × 30 days × Clear all
NCT07224464 2026-05-15

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

New Phase Ltd.

Phase NA Recruiting
12 enrolled
BreastGastrointestinalGynecologicThoracic

Hyperthermia, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡